BSTZ
BlackRock Science and Technology Trust II
There isn't enough reported data to score BSTZ yet.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
BSTZ Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Unavailable | |
| N/A | |
| N/A |
There isn't enough reported data to rate BSTZ's fundamentals.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
BSTZ PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 1.7x | $25.15 | โ |
| Cheap | 2.3x | N/A | N/A |
| Fair | 2.8x | N/A | N/A |
| Expensive | 6.8x | N/A | N/A |
Historical ranges are pointers, not guarantees.
BSTZ's PE is 1.7x, but its earnings don't support one, so it isn't a reliable read right now.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
BSTZ Forward outlook
There aren't enough analyst estimates for BSTZ to show an outlook.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
BSTZ Earnings Per Share
BSTZ and IREN do not have enough comparable growth data to identify a winner.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
BSTZ Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $208.6M | +66% |
| Q4 2025 | $140.6M | +47% |
| Q4 2024 | $95.6M | +32% |
| Q4 2023 | $72.3M | +1213% |
BSTZ has the edge over IREN in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 356% | N/A |
| Q4 2025 | 204% | +134 points |
| Q2 2025 | 22% | N/A |
| Q4 2024 | 80% | +1896 points |
| Q4 2023 | 71% | N/A |
| Q4 2022 | -1816% | N/A |
| Q2 2022 | -1108% | N/A |
BSTZ has the edge over IREN on profitability, with a higher operating margin.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was โ82% last quarter, down 50 points from the same quarter a year ago.
BSTZ Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$8.8M | +$5.6M |
| Q4 2025 | -$33.3M | -$6.3M |
| Q2 2025 | -$14.4M | +$37.2M |
| Q4 2024 | -$27.1M | -$19.6M |
| Q2 2024 | -$51.6M | -$24.8M |
| Q4 2023 | -$7.5M | -161% |
| Q2 2023 | -$26.8M | -184% |
BSTZ's free cash flow was โ$84M over the past year, against โ$74M the year before. Free cash flow isn't a meaningful measure for financial services companies like BSTZ.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was โ$2.5B over the past year, against โ$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
BSTZ Net Leverage
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
BSTZ Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.4 | Neutral |
| Stochastic | 13.6 | Oversold |
BSTZ's weekly RSI is 40 (neutral) and its Stochastic is 14 (oversold).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
BSTZ PE vs Financial Services Sector
| Metric | BSTZ | Sector median | Relative |
|---|---|---|---|
| PE | 1.7x | 13x | 87% below |
| PE % | 1 | 63 | 62 pts below |
BSTZ is trading at 1.7x earnings, a 87% discount to the Financial Services sector's median of 13x, though its earnings don't support one.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | โ |
IREN has no meaningful PE right now: it lost money over the past year.
BSTZ Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.7 | 9.1% below |
| 20 week MA | $29.0 | 13% below |
| 50 week MA | $26.4 | 4.7% below |
| 100 week MA | $23.5 | 7.2% above |
| 200 week MA | $20.8 | 21% above |
BSTZ has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
BSTZ Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $20.4 | $37.1 | +81% |
| 2021 | $37.1 | $38.1 | +2.7% |
| 2022 | $38.1 | $15.9 | -58% |
| 2023 | $15.9 | $16.7 | +5.4% |
| 2024 | $16.7 | $21.3 | +27% |
| 2025 | $21.3 | $22.9 | +7.4% |
| 2026 YTD | $22.9 | $25.2 | +10% |
BSTZ has the edge over IREN on returns for 2026, with the stronger performance.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to โ93% in 2022. It's down 52% so far in 2026.